We recently published a list of Why These 15 Industrial Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where INNOVATE Corp. (NYSE:VATE) stands against other ...
Every investor in INNOVATE Corp. (NYSE:VATE) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a ...
INNOVATE Corp. surged 150% after its subsidiary MediBeacon received FDA approval for its Transdermal Glomerular Filtration Rate (TGFR) system, boosting the market cap to $170 million. VATE's primary ...
VATE is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of VATE shares has decreased $0.20 since the market last closed. This is a 1.67% ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Find the Vate Tech financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the Vate Tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results